Pfizer keen on making its Covid-19 vaccine available in India, applies for regulatory approvals 

 
The results of a late phase trial of the vaccine in 6 countries on about 41,000 volunteers by the pharmaceutical majors have shown 95% efficacy against the infectious disease.